Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity of biologics in inflammatory bowel disease.
Vermeire S, Gils A, Accossato P, Lula S, Marren A. Vermeire S, et al. Among authors: marren a. Therap Adv Gastroenterol. 2018 Jan 21;11:1756283X17750355. doi: 10.1177/1756283X17750355. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 29383030 Free PMC article.
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.
Sands BE, Armuzzi A, Marshall JK, Lindsay JO, Sandborn WJ, Danese S, Panés J, Bressler B, Colombel JF, Lawendy N, Maller E, Zhang H, Chan G, Salese L, Tsilkos K, Marren A, Su C. Sands BE, et al. Among authors: marren a. Aliment Pharmacol Ther. 2020 Jan;51(2):271-280. doi: 10.1111/apt.15555. Epub 2019 Oct 29. Aliment Pharmacol Ther. 2020. PMID: 31660640 Free PMC article. Clinical Trial.
Ulcerative Colitis Treatment Patterns and Cost of Care.
Null KD, Xu Y, Pasquale MK, Su C, Marren A, Harnett J, Mardekian J, Manuchehri A, Healey P. Null KD, et al. Among authors: marren a. Value Health. 2017 Jun;20(6):752-761. doi: 10.1016/j.jval.2017.02.005. Epub 2017 Mar 22. Value Health. 2017. PMID: 28577692 Free article.
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply.
Sands BE, Armuzzi A, Marshall JK, Lindsay JO, Sandborn WJ, Danese S, Panés J, Bressler B, Colombel JF, Lawendy N, Maller E, Zhang H, Chan G, Salese L, Tsilkos K, Marren A, Su C. Sands BE, et al. Among authors: marren a. Aliment Pharmacol Ther. 2020 May;51(10):997-998. doi: 10.1111/apt.15716. Aliment Pharmacol Ther. 2020. PMID: 32338784 No abstract available.
Tofacitinib is not a biologic.
Marren AS. Marren AS. Ann Gastroenterol. 2017;30(1):134. doi: 10.20524/aog.2016.0094. Epub 2016 Oct 7. Ann Gastroenterol. 2017. PMID: 28042254 Free PMC article. No abstract available.
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E. Panés J, et al. Among authors: marren a. Gut. 2017 Jun;66(6):1049-1059. doi: 10.1136/gutjnl-2016-312735. Epub 2017 Feb 16. Gut. 2017. PMID: 28209624 Free PMC article. Clinical Trial.
26 results